Bridgeway Capital Management, LLC X Biotech Inc. Transaction History

Bridgeway Capital Management, LLC

$3.75 Billion
Q1 2025

A detailed history of Bridgeway Capital Management, LLC transactions in X Biotech Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 123,032 shares of XBIT stock, worth $359,253. This represents 0.01% of its overall portfolio holdings.

Number of Shares

123,032

Previous 144,630 14.93%

Holding current value

$359,253

Previous $571,000 30.3%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.99 - $4.48 $64,578 - $96,759	-21,598 Reduced 14.93%	123,032 $398,000
Q4 2024 Feb 14, 2025	SELL	$3.8 - $8.25 $11,255 - $24,436	-2,962 Reduced 2.01%	144,630 $571,000
Q3 2024 Nov 14, 2024	SELL	$5.55 - $7.95 $36,552 - $52,358	-6,586 Reduced 4.27%	147,592 $1.14 Million
Q2 2024 Aug 14, 2024	BUY	$4.54 - $9.89 $22,064 - $48,065	4,860 Added 3.25%	154,178 $792,000
Q1 2024 May 15, 2024	BUY	$4.03 - $8.13 $19,041 - $38,414	4,725 Added 3.27%	149,318 $1.21 Million
Q4 2023 Feb 14, 2024	BUY	$3.56 - $4.65 $19,053 - $24,886	5,352 Added 3.84%	144,593 $578,000
Q3 2023 Nov 14, 2023	BUY	$4.02 - $5.81 $50,511 - $73,002	12,565 Added 9.92%	139,241 $573,000
Q2 2023 Aug 14, 2023	BUY	$3.06 - $6.38 $37,748 - $78,703	12,336 Added 10.79%	126,676 $752,000
Q1 2023 May 15, 2023	SELL	$3.22 - $4.72 $29,173 - $42,763	-9,060 Reduced 7.34%	114,340 $394,000
Q4 2022 Feb 14, 2023	SELL	$3.03 - $3.79 $29,087 - $36,384	-9,600 Reduced 7.22%	123,400 $433,000
Q3 2022 Nov 14, 2022	BUY	$3.58 - $5.88 $366,950 - $602,700	102,500 Added 336.07%	133,000 $481,000
Q2 2022 Aug 15, 2022	BUY	$5.13 - $9.2 $156,465 - $280,600	30,500 New	30,500 $172,000
Q3 2020 Nov 16, 2020	SELL	$13.97 - $21.16 $311,531 - $471,868	-22,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.39 - $16.07 $231,697 - $358,361	22,300 New	22,300 $306,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

3.97M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $88.9M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC X Biotech Inc. Transaction History